Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Detry-Morel

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal Francais D'Ophtalmologie|April 30, 1999
[Prospects in the medical treatment of glaucomatous neuropathy. Basics of neuroprotection]M Detry-Morel
Journal Francais D'Ophtalmologie|June 3, 2011
[Is myopia a risk factor for glaucoma?]M Detry-Morel
Journal Francais D'Ophtalmologie|November 30, 2007
[Glaucoma in the over-eighties]M Detry-Morel
Journal Francais D'Ophtalmologie|January 1, 1981
[Vascular glaucoma]M Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|January 1, 1995
[Neovascular glaucoma in the diabetic patient]M Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|February 12, 2011
[The six keys of the monitoring of the glaucoma patient]M Detry-Morel
Journal Francais D'Ophtalmologie|January 1, 1981
[The eye and cavernous sinus disorders (author's transl)]M Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|November 12, 1998
[Combined interventions: cataract and glaucoma review of the literature]M Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|January 30, 2010
Ophthalmoscopic presentation of presumed retinal glial cell activation (ARAM) in a glaucoma patientM Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|September 27, 2007
Update in tonometry. Phosphene and rebound tonometries, self-tonometry and technologies for the futureM Detry-Morel
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal Francais D'Ophtalmologie|April 30, 1999
[Prospects in the medical treatment of glaucomatous neuropathy. Basics of neuroprotection]M Detry-Morel
Journal Francais D'Ophtalmologie|June 3, 2011
[Is myopia a risk factor for glaucoma?]M Detry-Morel
Journal Francais D'Ophtalmologie|November 30, 2007
[Glaucoma in the over-eighties]M Detry-Morel
Journal Francais D'Ophtalmologie|January 1, 1981
[Vascular glaucoma]M Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|January 1, 1995
[Neovascular glaucoma in the diabetic patient]M Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|February 12, 2011
[The six keys of the monitoring of the glaucoma patient]M Detry-Morel
Journal Francais D'Ophtalmologie|January 1, 1981
[The eye and cavernous sinus disorders (author's transl)]M Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|November 12, 1998
[Combined interventions: cataract and glaucoma review of the literature]M Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|January 30, 2010
Ophthalmoscopic presentation of presumed retinal glial cell activation (ARAM) in a glaucoma patientM Detry-Morel
Bulletin De La Societe Belge D'Ophtalmologie|September 27, 2007
Update in tonometry. Phosphene and rebound tonometries, self-tonometry and technologies for the futureM Detry-Morel
Pageof 6